Document Detail


Natriuretic peptides in the prognosis and management of acute coronary syndromes.
MedLine Citation:
PMID:  20700099     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Over the past decade, an evidence base has accumulated to support natriuretic peptide (NP) testing for diagnosis, risk assessment, and therapeutic monitoring and guidance of patients with heart failure. Investigators have also explored multiple other potential uses for these tests, including risk assessment of patients with suspected acute coronary syndromes (ACS). This article discusses the utility of NPs in the diagnosis and management of patients with ACS.
Authors:
James A de Lemos; W Frank Peacock; Peter A McCullough
Related Documents :
20425159 - Coronary intervention in patients with acute coronary syndrome: does every culprit lesi...
17707099 - Coronary spasm and hypersensitivity to amoxicillin: kounis or not kounis syndrome?
937279 - Mucocutaneous lymph node syndrome in denver.
14733789 - The role of inflammatory stress in acute coronary syndrome.
21253269 - The "i-never-took-pills-before" syndrome and the treatment of hypertension.
17186009 - Two cases of rapid onset parkinson's syndrome following toxic ingestion of ethylene gly...
23093789 - Genetic "lnc"-age of noncoding rnas to human disease.
3362309 - Arthrogryposis multiplex congenita associated with lissencephaly: a case report.
8956089 - Cross-cultural generalizability of the youth self-report and teacher's report form cros...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Reviews in cardiovascular medicine     Volume:  11 Suppl 2     ISSN:  1530-6550     ISO Abbreviation:  Rev Cardiovasc Med     Publication Date:  2010  
Date Detail:
Created Date:  2010-08-11     Completed Date:  2010-10-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960007     Medline TA:  Rev Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S24-34     Citation Subset:  IM    
Affiliation:
Donald W. Reynolds Cardiovascular Research Center and Division of Cardiology, University of Texas Southwestern Medical Center, Dallas TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Coronary Syndrome / blood*,  diagnosis,  mortality,  therapy
Biological Markers / blood
Evidence-Based Medicine
Humans
Natriuretic Peptide, Brain / blood*
Peptide Fragments / blood
Predictive Value of Tests
Risk Assessment
Risk Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Peptide Fragments; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differential diagnosis and overlap of acute chest discomfort and dyspnea in the emergency department...
Next Document:  Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers.